Modelling cytomegalovirus replication patterns in the human host: Factors important for pathogenesis

Proceedings of the Royal Society B: Biological Sciences

Volumn 273, Issue 1596, 2006, Pages 1961-1967

  Regoes, Roland R ^a   Bowen, E Frances ^b   Cope, Alethea V ^b   Gor, Dehila ^b   Hassan Walker, Aycan F ^b   Prentice, H Grant ^c   Johnson, Margaret A ^b   Sweny, Paul ^b   Burroughs, Andrew K ^c   Griffiths, Paul D ^b   Bonhoeffer, Sebastian ^a   Emery, Vincent C ^b  

^a ETH ZURICH   (Switzerland)

^b ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^c UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

Disease; Models; Virus replication

Indexed keywords

MODELING; PATHOGEN; PATHOLOGY; VIRAL DISEASE; VIRUS;

ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; CYTOMEGALOVIRUS INFECTION; DISEASE COURSE; GASTROINTESTINAL DISEASE; HEPATITIS; HOST; HOST PARASITE INTERACTION; HUMAN; HUMAN CYTOMEGALOVIRUS; IMMUNE DEFICIENCY; MAJOR CLINICAL STUDY; PNEUMONIA; PRIORITY JOURNAL; RETINITIS; STATISTICAL MODEL; VIRUS LOAD; VIRUS REPLICATION; CYTOMEGALIC INCLUSION BODY DISEASE; CYTOMEGALOVIRUS; FEVER; IMMUNOLOGY; PATHOGENICITY; PHYSIOLOGY; VIROLOGY;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; CYTOMEGALOVIRUS RETINITIS; FEVER; GASTROINTESTINAL DISEASES; HEPATITIS; HUMANS; IMMUNOCOMPROMISED HOST; MODELS, STATISTICAL; PNEUMONIA; VIRAL LOAD; VIRUS REPLICATION;

EID: 33750606843     PISSN: 09628452     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rspb.2006.3506     Document Type: Article

References (43)

1. Appay, V. et al. 2002 Memory CD8+T cells vary in differentiation phenotype in different persistent virus infections. Nat. Med. 8, 379-385. (doi:10.1038/nm0402-379)
2. Barry, S. M., Johnson, M. A. & Janossy, G. 2000 Cytopathology or immunopathology? The puzzle of cytomegalovirus pneumonitis revisited. Bone Marrow Transplant. 26, 591-597. (doi:10.1038/sj.bmt.1702562)
3. Bowen, E. F., Sabin, C. A., Wilson, P., Grifiths, P. D., Davey, C. C., Johnson, M. A. & Emery, V. C. 1997 Cytomegalovirus (CMV) viraemia detected by polymerase chain reaction identifies a group of HIV-positive patients at high risk of CMV disease. AIDS 11, 889-893. (doi:10.1097/00002030- 199707000-00008)
4. Bronke, C., Westerlaken, G. H., Miedema, F., Tessalaar, K. & van Baarle, D. 2005a Progression to CMV end-organ disease in HIV-1 infected individuals despite abundance of highly differentiated CMV-specific CD8+T-cells. Immunol. Lett. 97, 215-224. (doi:10.1016/j.imlet.2004.11.004)
5. Bronke, C. et al. 2005b Dynamics of cytomegalovirus (CMV)-specific T-cells in HIV-1 infected individuals progressing to AIDS with CMV end-organ disease. J. Infect. Dis. 191, 873-880. (doi:10.1086/427828)
6. Bunde, T. et al. 2005 Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells. J. Exp. Med. 201, 1031-1036. (doi:10.1084/jem.20042384)
7. Cope, A. V., Sabin, C., Burroughs, A., Rolles, K., Griffiths, P. D. & Emery, V. C. 1997 Interrelationships among quantity of human cytomegalovirus (HCMV) DNA in blood, donor-recipient serostatus, and administration of methylprednisolone as risk factors for HCMV disease following liver transplantation. J. Infect. Dis. 176, 1484-1490.
8. Deayton, J. R., Sabin, C. A., Johnson, M. A., Emery, V. C., Wilson, P. & Griffiths, P. D. 2004 Importance of cytomegalovirus viraemia in risk of disease progression and death in HIV-infected patients receiving highly active antiretroviral therapy. Lancet 363, 2116-2121. (doi:10.1016/S0140-6736(04)16500-8)
9. Dejaco-Ruhswurm, I., Kiss, B., Rainer, G., Krepler, K., Wedrich, A., Dallinger, S., Rieger, A. & Schmetterer, L. 2001 Ocular blood flow in patients infected with human immunodeficiency virus. Am. J. Ophthalmol. 132, 720-726. (doi:10.1016/S0002-9394(01)01095-9)
10. Dunn, J. P. & Jabs, D. A. 1995 Cytomegalovirus retinitis in AIDS: natural history, diagnosis, and treatment. AIDS Clin. Rev. 96, 99-129.
11. Emery, V. C. 2001 Investigation of CMV disease in immunocompromised patients. J. Clin. Pathol. 54, 84-88. (doi:10.1136/jcp.54.2.84)
12. Emery, V. C., Cope, A. V., Bowen, E. F., Gor, D. & Griffiths, P. D. 1999a The dynamics of human cytomegalovirus replication in vivo. J. Exp. Med. 190, 177-182. (doi:10.1084/jem.190.2.177)
13. Emery, V. C., Sabin, C., Feinberg, J. E., Gryzwacz, M., Knight, S., Griffiths, P. D. & on behalf of the ACTG 204/GlaxoWellcome 123-014 International CMV Prophylaxis Study Group 1999b Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. J. Infect. Dis. 180, 695-701. (doi:10.1086/314936)
14. Emery, V. C., Sabin, C. A., Cope, A. V., Gor, D., Hassan-Walker, A. F. & Griffiths, P. D. 2000 Application of viral-load kinetics to identify patients who develop cytomegalovirus disease after transplantation. Lancet 355, 2032-2036. (doi:10.1016/S0140-6736(00)02350-3)
15. Emery, V. C., Hassan-Walker, A. F., Burroughs, A. K. & Griffiths, P. D. 2002 Human cytomegalovirus (HCMV) replication dynamics in HCMV-naive and -experienced immunocompromised hosts. J. Infect. Dis. 185, 1723-1728. (doi:10.1086/340653)
16. Fox, J. C., Griffiths, P. D. & Emery, V. C. 1992 Quantification of human cytomegalovirus DNA using the polymerase chain reaction. J. Gen. Virol. 73, 2405-2408.
17. Fox, J. C., Kidd, I. M., Griffiths, P. D., Sweny, P. & Emery, V. C. 1995 Longitudinal analysis of cytomegalovirus load in renal transplant recipients using a quantitative polymerase chain reaction: correlation with disease. J. Gen. Virol. 76, 309-319.
18. Gillespie, G. M. et al. 2000 Functional heterogeneity and high frequencies of cytomegalovirus-specific CD8(+) T lymphocytes in healthy seropositive donors. J. Virol. 74, 8140-8150. (doi:10.1128/JVI.74. 17.8140-8150.2000)
19. Gor, D., Sabin, C., Prentice, H. G., Vyas, N., Man, S., Griffiths, P. D. & Emery, V. C. 1998 Longitudinal fluctuations in cytomegalovirus load in bone marrow transplant patients: relationship between peak virus load, donor/recipient serostatus, acute GVHD and CMV disease. Bone Marrow Transpant. 21, 597-605. (doi:10. 1038/sj.bmt.1701139)
20. Hassan-Walker, A. F., Kidd, I. M., Sabin, C., Sweny, P., Griffiths, P. D. & Emery, V. C. 1999 Quantity of human cytomegalovirus (CMV) DNAemia as a risk factor for CMV disease in renal allograft recipients: relationship with donor/recipient CMV serostatus, receipt of augmented methylprednisolone and antithymocyte globulin (ATG). J. Med. Virol. 58, 182-187. (doi:10.1002/(SICI)1096-9071(199906)58:2〈182::AID-JMV14〉3.0.CO;2-Q)
21. Ho, M. 1994 Advances in understanding cytomegalovirus infection after transplantation. Transplant. Proc. 26, 7-11.
22. Hoover, D. R., Peng, Y., Saah, A., Semba, R., Detels, R. R., Rinaldo Jr, C. R. & Phair, J. P. 1996 Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression. Arch. Ophthalmol. 114, 821-827.
23. Kalejta, R. F. & Shenk, T. 2002 Manipulation of the cell cycle by human cytomegalovirus. Front. Biosci. 7, 295-306.
24. Lilley, B. N. & Ploegh, H. L. 2004 A membrane protein required for dislocation of misfolded proteins from the ER. Nature 429, 834-840. (doi:10.1038/nature02592)
25. Lilley, B. N., Ploegh, H. L. & Tirabassi, R. S. 2001 Human cytomegalovirus open reading frame TRL11/IRL11 encodes an immunoglobulin G Fc-binding protein. J. Virol. 75, 11 218-11 221. (doi:10.1128/JVI.75.22.11218-11221.2001)
26. Lim, M. C., Cumberland, W. G., Minassian, S. L., Ransome, S. S., Cornish, M. J., Terry, B. G. & Holland, G. N. 2001 Decreased macular leukocyte velocity in human immunodeficiency virus-infected individuals. Am. J. Ophthalmol. 132, 711-719. (doi:10.1016/S0002-9394(01)01201-6)
27. Limaye, A. P., Huang, M. L., Leisenring, W., Stensland, L., Corey, L. & Boeckh, M. 2001 Cytomegalovirus (CMV) DNA load in plasma for the diagnosis of CMV disease before engraftment in hematopoietic stem-cell transplant recipients. J. Infect. Dis. 183, 377-382. (doi:10.1086/318089)
28. Ljungman, P., Griffiths, P. D. & Paya, C. 2002 Definitions of cytomegalovirus infection and disease in transplant recipients. Clin. Infect. Dis. 34, 1094-1097. (doi:10.1086/339329)
29. Mann, M. et al. 1997 Lack of clinical utility of bronchoalveolar lavage cultures for cytomegalovirus in HIV infection. Am. J. Respir. Crit. Care Med. 155, 1723-1728.
30. McLaughlin-Taylor, E., Pande, H., Forman, S. J., Tanamachi, B., Li, C. R., Zaia, J. A., Greenberg, P. D. & Riddell, S. R. 1994 Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes. J. Med. Virol. 43, 103-110.
31. Mocarski, E. S. 2002 Immunomodulation by cytomegaloviruses: manipulative strategies beyond evasion. Trends Microbiol. 10, 332-339. (doi:10.1016/S0966-842X(02)02393-4)
32. Nichols, W. G. & Boeckh, M. 2000 Recent advances in the therapy and prevention of CMV infections. J. Clin. Virol. 16, 25-40. (doi:10.1016/S1386-6532(99)00065-7)
33. Ontanon, J., Muro, M., Garcia-Alonso, A. M., Minguela, A., Torio, A., Bermejo, J., Pons, J. A., Campos, M. & Alvarez-Lopez, M. R. 1998 Effect of partial HLA class I match on acute rejection in viral pre-infected human liver allograft recipients. Transplantation 65, 1047-1053. (doi:10.1097/00007890-199804270-00007)
34. Regoes, R. R., Staprans, S. I., Feinberg, M. B. & Bonhoeffer, S. 2002 Contribution of peaks of virus load to simian immunodeficiency virus pathogenesis. J. Virol. 76, 2573-2578. (doi:10.1128/jvi.76.5.2573- 2578.2002)
35. Rehm, A., Engelsberg, A., Tortorella, D., Korner, I. J., Lehmann, I., Ploegh, H. L. & Hopken, U. E. 2002 Human cytomegalovirus gene products US2 and US11 differ in their ability to attack major histocompatibility class I heavy chains in dendritic cells. J. Virol. 76, 5043-5050. (doi:10.1128/JVI.76.10.5043-5050.2002)
36. Sacre, K. et al. 2005 Repertoire, diversity, and differentiation of specific CD8 T-cells are associated with immune protection against human cytomegalovirus disease. J. Exp. Med. 201, 1999-2010. (doi:10.1084/jem.20042408)
37. Schafer, P., Tenschert, W., Cremaschi, L., Schroter, M., Zollner, B. & Laufs, R. 2001 Area under the viraemia curve versus absolute viral load: utility for predicting symptomatic cytomegalovirus infections in kidney transplant patients. J. Med. Virol. 65, 85-89. (doi:10.1002/jmv.2005)
38. Shinkai, M., Bozzette, S. A., Powderly, W., Frame, P. & Spector, S. A. 1997 Utility of urine and leukocyte cultures and plasma DNA polymerase chain reaction for identification of AIDS patients at risk for developing human cytomegalovirus disease. J. Infect. Dis. 175, 302-308.
39. Spector, S. A., Wong, R., Hsia, K., Pilcher, M. & Stempien, M. J. 1998 Plasma cytomegalovirus (CMV) DNA load predicts CMV disease and survival in AIDS patients. J. Clin. Invest. 101, 497-502.
40. Squire, S. B., Lipman, M. C., Bagdades, E. K., Mulvenna, P. M., Grundy, J. E., Griffiths, P. D. & Johnson, M. A. 1992 Severe cytomegalovirus pneumonitis in HIV infected patients with higher than average CD4 counts. Thorax 47, 301-304.
41. Sylwester, A. W. et al. 2005 Broadly targeted human cytomegalovirus-specific CD4+ and CD8+T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 202, 673-685. (doi:10.1084/jem.20050882)
42. Tirabassi, R. S. & Ploegh, H. L. 2002 The human cytomegalovirus US8 glycoprotein binds to major histocompatibility complex class I products. J. Virol. 76, 6832-6835. (doi:10.1128/JVI.76.13.6832-6835.2002)
43. Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J. & Ploegh, H. L. 2000 Viral subversion of the immune system. Annu. Rev. Immunol. 18, 861-926. (doi:10.1146/annurev.immunol.18.1.861)